Tyra Biosciences, Inc.
Company Stats
- Market Cap
- $1.3B
- as of Sep 30, 2026
- Shares Outstanding
- 59.7M
- Free Float
- 38.0%
Income Statement
- Operating Income
- -$132.8M
- Net Income
- -$119.9M
- EBITDA
- -$132.2M
Cash Flow
- Free Cash Flow
- -$95.3M
- FCF Yield
- -7.3%
- Owner FCF Yield
- -9.4%
Balance Sheet
- Cash & Equivalents
- $77.4M
Returns & Capital
- SBC, 3Y Avg
- $21.4M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$95.3M | — |
| FY2024 | — | -$70.4M | — |
| FY2023 | — | -$50.9M | — |
| FY2022 | — | -$50.8M | — |
| FY2021 | — | -$24.4M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges